CARPRIEVE 100 MG TABLETS FOR DOGS.
Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Lastnosti izdelka
(SPC)
05-05-2024
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
CARPROFEN
Dostopno od:
Norbrook Laboratories Limited
Koda artikla:
QM01AE91
INN (mednarodno ime):
CARPROFEN
Odmerek:
100 Milligram
Farmacevtska oblika:
Tablets
Tip zastaranja:
POM
Terapevtska skupina:
Canine
Terapevtsko območje:
Carprofen
Terapevtske indikacije:
N.S.A.I.D
Status dovoljenje:
Authorised
Datum dovoljenje:
2010-01-08
Lastnosti izdelka
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 100 mg Tablets for Dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE INGREDIENTS:
Carprofen
100 mg
EXCIPIENTS:
Tartrazine (E102)
1.2 mg
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
A yellow circular tablet of 8 mm diameter, embossed “100” on one side and a single breakline on the other side.
The tablets can be divided into halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In the dog:
Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow
up to parenteral analgesia in the management of post operative pain.
4.3 CONTRAINDICATIONS
Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in puppies less than 4 months of age.
Do not use in animals with known hypersensitivity to the active substance or to any of the excipients.”
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal
ulceration or bleeding, or where there is evidence of a blood dyscrasia.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to Sections 4.3 and 4.5.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 04/07/2014_
_CRN 7015268_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Use in aged dogs may involve additional risk.
If such a use cannot be avoided, such dogs may require a reduced dosage and careful clinical management.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory con
Preberite celoten dokument
